A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine (Q66403034)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine |
clinical trial |
Statements
Hantaan Virus Plasmid DNA (Expressing Gn and Gc Antigens; E. Coli; Althea Technologies, Inc.) Vaccine Hantaan [HTNV-DNA Vaccine] and Puumala Virus DNA (Expressing Gn and Gc Antigens; E. Coli; Althea Technologies, Inc.) Vaccine Puumala [PUUV-DNA Vaccine] Administered Via Stratus Needle-free Injection System (PharmaJet, Inc.) (English)
0 references
30 August 2016
0 references
November 2019
0 references
27
0 references
18 year
0 references
49 year
0 references